Press Release Oct 31 2025
Filed with NSE · · 3 pages · English
Summary by 6ix AI
The company reported a revenue increase compared to the same period last year, along with growth in EBITDA and profit after tax. Additionally, an interim dividend has been declared and a bonus issue has been approved by the board.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Dr. Lal PathLabs Limited on 6ix
Earlier from Dr. Lal PathLabs
- Press Release Aug 20 2025
- Press Release Jul 31 2025
- Press Release Jun 25 2025
- Press Release Apr 25 2025
- Press Release Apr 15 2025
Later from Dr. Lal PathLabs
- Dr. Lal Pathlabs Limited Press Release Nov 26 2025
- Dr. Lal Pathlabs Limited Press Release Jan 06 2026
- Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD™ Test in India
- Press Release Jan 30 2026
- Press Release Apr 30 2026
Follow Dr. Lal PathLabs into a list and get an email when it puts out news.
Follow Dr. Lal PathLabs